India Glycols Ltd Upgraded to Hold on Improved Technicals and Attractive Valuation

Technical Trends Shift to Bullish Momentum

The primary catalyst for the upgrade stems from a marked improvement in the company’s technical profile. The technical trend has shifted from a sideways pattern to a bullish one, supported by multiple indicators across different time frames. On the weekly chart, the Moving Average Convergence Divergence (MACD) is bullish, as is the monthly MACD, indicating sustained upward momentum. Similarly, Bollinger Bands on both weekly and monthly charts suggest a positive price breakout, while daily moving averages confirm a bullish stance.

Other technical signals reinforce this positive outlook: the Know Sure Thing (KST) indicator is bullish on a weekly basis, though mildly bearish monthly readings suggest some caution. The Dow Theory also supports a bullish trend on both weekly and monthly scales. Meanwhile, the On-Balance Volume (OBV) indicator shows bullish momentum weekly, though it remains neutral monthly. Despite a weekly Relative Strength Index (RSI) reading that is bearish, the overall technical picture favours upward price movement.

These technical improvements have coincided with a strong price performance, with the stock closing at ₹266.00 on 7 September 2026, marking a 4.99% gain on the day and reaching its 52-week high. This price strength contrasts favourably with the broader Sensex, which has underperformed over multiple periods.

Valuation Metrics Now Very Attractive

Alongside technical improvements, India Glycols’ valuation grade has been upgraded from fair to very attractive. The company currently trades at a price-to-earnings (PE) ratio of 5.63, significantly lower than many of its peers in the commodity chemicals industry, which often trade at PE multiples exceeding 30. The price-to-book value stands at a modest 0.61, while enterprise value to EBITDA is 5.12, underscoring the stock’s undervaluation relative to earnings and asset base.

Other valuation ratios further support this positive assessment: the enterprise value to capital employed is just 0.75, and the PEG ratio is an exceptionally low 0.01, indicating that earnings growth is not yet fully priced in. The company also offers a healthy dividend yield of 4.56%, attractive for income-focused investors. Return on capital employed (ROCE) and return on equity (ROE) are 10.80% and 10.00% respectively, reflecting reasonable profitability levels for a small-cap chemical firm.

Compared to industry peers such as Navin Fluorine International and Himadri Speciality Chemicals, which are rated as very expensive with PE ratios above 40 and EV/EBITDA multiples exceeding 30, India Glycols presents a compelling value proposition for investors seeking exposure to the commodity chemicals sector at a discount.

Robust Financial Trend with Consistent Profit Growth

India Glycols has demonstrated positive financial performance over recent quarters, with six consecutive quarters of profit growth. The company’s first quarter results for FY26-27 showed a return on capital employed (ROCE) at a half-year high of 11.79%, while operating profit to interest coverage ratio reached 6.73 times, signalling strong operational efficiency and debt servicing capability. The debt-to-equity ratio remains conservative at 0.58 times, indicating a manageable leverage position.

Over the past year, the stock has delivered a total return of 45.00%, significantly outperforming the Sensex’s negative 5.21% return over the same period. Earnings growth has been robust, with profits rising by approximately 30% year-on-year. The company’s net sales have grown at an annualised rate of 8.63% over five years, while operating profit has expanded at 18.75% annually, reflecting steady business expansion and margin improvement.

Despite these positives, some long-term fundamental challenges remain. The average ROCE over the last five years is a moderate 8.62%, and the company’s debt to EBITDA ratio of 2.60 times suggests a relatively higher debt burden compared to peers. Additionally, domestic mutual funds hold a small stake of only 0.56%, which may indicate limited institutional conviction or concerns about the company’s growth prospects at current valuations.

Quality Assessment and Market Position

India Glycols holds a Mojo Score of 60.0, which corresponds to a Hold rating, upgraded from a previous Sell grade. This score reflects a balanced view of the company’s quality, valuation, financial trend, and technicals. The company operates in the commodity chemicals sector, a segment characterised by cyclical demand and pricing volatility, which can impact earnings stability.

While the company’s recent financial and technical improvements are encouraging, its small-cap status and relatively modest institutional ownership suggest that investors should remain cautious. The stock’s strong historical returns over longer periods are notable, with a 10-year return exceeding 2,100%, vastly outperforming the Sensex’s 168% gain over the same timeframe. This long-term performance underscores the company’s ability to generate shareholder value despite sector headwinds.

However, the company’s moderate profitability metrics and debt levels indicate that it is not without risks. Investors should weigh these factors carefully when considering India Glycols as part of a diversified portfolio.

Conclusion: A Balanced Upgrade Reflecting Improved Outlook

The upgrade of India Glycols Ltd from Sell to Hold is driven by a confluence of factors. The technical landscape has turned decisively bullish, with multiple indicators signalling positive momentum. Valuation metrics now classify the stock as very attractive, trading at significant discounts to peers and supported by strong dividend yield and reasonable profitability. Financial trends show consistent profit growth and improved operational efficiency, although some long-term fundamental weaknesses persist.

For investors, this rating change suggests that India Glycols is no longer a clear underperformer but rather a stock with potential for steady gains, albeit with some caution warranted due to sector cyclicality and financial leverage. The Hold rating reflects a balanced stance, recognising both the recent positive developments and the challenges ahead.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →